Astana Biomed Group, an authorized Abcam distributor in Central Asia

Anti-IGFBP5 antibody [EPR18013-137] (ab254324)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR18013-137] to IGFBP5
  • Suitable for: WB, IP
  • Reacts with: Mouse, Rat

Overview

  • Product name

    Anti-IGFBP5 antibody [EPR18013-137]
    See all IGFBP5 primary antibodies

  • Description

    Rabbit monoclonal [EPR18013-137] to IGFBP5

  • Host species

    Rabbit

  • Tested Applications & Species

    Application Species
    IP
    Mouse
    WB
    Mouse
    Rat
    See all applications and species data

  • Immunogen

    Recombinant fragment. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: Untreated C2C12 and C2C12 treated with 2% horse serum for 6 days whole cell lysate; Mouse lung tissue lysate; Rat uterus tissue lysate. IP: C2C12 (Mouse myoblasts myoblast) whole cell lysate.

  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

    The Life Science industry has been in the grips of a reproducibility crisis for a number of years. Abcam is leading the way in addressing the problem with our range of recombinant monoclonal antibodies and knockout edited cell lines for gold-standard validation.

    One factor contributing to the crisis is the use of antibodies that are not suitable. This can lead to misleading results and the use of incorrect data informing project assumptions and direction. To help address this challenge, we have introduced an application and species grid on our primary antibody datasheets to make it easy to simplify identification of the right antibody for your needs.

    Learn more here.

Properties

Images

  • Western blot - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    Western blot - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    Anti-IGFBP5 antibody [EPR18013-137] (ab254324) at 1/1000 dilution + Rat uterus tissue lysate at 20 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/50000 dilution

    Predicted band size: 31 kDa
    Observed band size: 34, 16 kDa
    why is the actual band size different from the predicted?



    IGFBP5 can be processed into approximately 16 kDa fragment. The molecular weight observed is consistent with what has been described in the literature (PMID: 11701437, PMID:11920405).

    Blocking/Diluting buffer and concentration: 5% NFDM/TBST

    Exposure time: 92 seconds

  • Western blot - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    Western blot - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    Anti-IGFBP5 antibody [EPR18013-137] (ab254324) at 1/1000 dilution + Mouse lung tissue lysate at 20 µg

    Secondary
    Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/100000 dilution

    Predicted band size: 31 kDa



    IGFBP5 can be processed into approximately 16 kDa fragment. The molecular weight observed is consistent with what has been described in the literature (PMID: 11701437, PMID:11920405).

    Blocking/Diluting buffer and concentration: 5% NFDM/TBST

    Exposure time: 3 minutes

  • Western blot - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    Western blot - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    All lanes : Anti-IGFBP5 antibody [EPR18013-137] (ab254324) at 1/1000 dilution

    Lane 1 : Untreated C2C12 (mouse myoblasts myoblast), whole cell lysate
    Lane 2 : C2C12 treated with 2% horse serum for 6 days, whole cell lysate

    Secondary
    All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/50000 dilution

    Predicted band size: 31 kDa
    Observed band size: 34, 16 kDa why is the actual band size different from the predicted?



    The level of IGFBP5 expression is elevated in C2C12 after differentiation. (PMID: 7693664)

    IGFBP5 can be processed into approximately 16 kDa fragment. The molecular weight observed is consistent with what has been described in the literature (PMID: 11701437, PMID:11920405)

    Exposure time: 7.75 seconds

    Blocking/diluting buffer and concentration: 5% NFDM/TBST 

  • Immunoprecipitation - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    Immunoprecipitation - Anti-IGFBP5 antibody [EPR18013-137] (ab254324)

    IGFBP5 was immunoprecipitated from 0.35 mg C2C12 (Mouse myoblasts myoblast) whole cell lysate using ab254324 at 1/30 dilution. Western blot was perfromed from the immunoprecipitate using ab254324 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366) was used at 1/5000 dilution.

    Lane 1: C2C12 whole cell lysate 10 µg (input)
    Lane 2: ab254324 IP in C2C12 whole cell lysate.
    Lane 3: Rabbit monoclonal IgG (ab172730) instead of ab254324 in C2C12 whole cell lysate.

    Blocking and dilution buffer and concentration: 5% NFDM/TBST.

    Exposure time: 1 minute.

     

  • Anti-IGFBP5 antibody [EPR18013-137] (ab254324)
    Anti-IGFBP5 antibody [EPR18013-137] (ab254324)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-IGFBP5 antibody [EPR18013-137] (ab254324)

© 2021 Astana Biomed Group LLP. All rights reserved.